ROIV
NASDAQ · Biotechnology
Roivant Sciences Ltd
$36.34
+1.22 (+3.47%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+32.87%
1Y
+225.34%
YTD
+65.71%
Open$35.88
Previous Close$35.12
Day High$36.44
Day Low$35.62
52W High$37.00
52W Low$10.90
Volume—
Avg Volume5.35M
Market Cap26.25B
P/E Ratio—
EPS$-0.45
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$23.00
Above
SMA 200
$16.34
Above
RSI (14)
76.4
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+121.3% upside
Current
$36.34
$36.34
Target
$80.43
$80.43
$62.72
$80.43 avg
$106.86
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.60M | 16.77M | 2.76B |
| Net Income | -312,079,486 | -547,828,237 | -140,854,131 |
| Profit Margin | -3,629.2% | -3,447.7% | -5.1% |
| EBITDA | -521,288,327 | -965,913,615 | -182,068,335 |
| Free Cash Flow | — | — | -125,369,781 |
| Rev Growth | -48.7% | -48.7% | -1.7% |
| Debt/Equity | — | — | 0.56 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |